![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Geron Issues $4 Million Equity to Hong Kong Investors
Geron Issues $4 Million Equity to Hong Kong Investors
April 25, 2005
Geron Corp. sold $4 million worth of stock and warrants to prominent Hong Kong investors to fund Geron's financial commitment to TA Therapeutics Ltd. TA Therapeutics is 50 percent owned by Geron and 50 percent owned by its research partner Biotechnology Research Corp. and is developing drugs to restore cells that have been affected by senescence, injury or chronic disease.
Yahoo News (http://biz.yahoo.com/cbsmb/050425/856837d24e0a44f1a338ba06b2f42936.html?.v=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct